Boiron SA (BOIRF)
OTCMKTS · Delayed Price · Currency is USD
24.00
0.00 (0.00%)
At close: Aug 6, 2025
Paramount Global Market Cap
Boiron has a market cap or net worth of $434.86 million as of August 12, 2025. Its market cap has decreased by -27.43% in one year.
Market Cap
434.86M
Enterprise Value
377.23M
Revenue
504.77M
Ranking
n/a
PE Ratio
37.05
Stock Price
$24.00
Market Cap Chart
Since January 19, 1994, Boiron's market cap has increased from 197.69M to 434.86M, an increase of 119.97%. That is a compound annual growth rate of 2.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2025 | 434.86M | -9.73% |
| Dec 31, 2024 | 481.74M | -37.59% |
| Dec 29, 2023 | 771.87M | -17.98% |
| Dec 30, 2022 | 941.08M | 32.13% |
| Dec 31, 2021 | 712.26M | -19.57% |
| Dec 31, 2020 | 885.60M | 23.81% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.72M |
| Veradigm | 789.71M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 610.23M |
| Glass House Brands | 561.16M |
| American Oncology Network | 385.65M |
| Northwest Biotherapeutics | 360.45M |
| CytoDyn | 300.75M |